Skip to main content
Signal8
Gathagan Bryan K. profile photo

Bryan K. Gathagan

CIK: 0001981919

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMMUCELL CORP /DE/ logo
ICCC

IMMUCELL CORP /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Jun 12, 2025
    Purchase(P)
    Direct
    1K shares at avg. $6.32$6K
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Apr 16, 2025
    Award(A)

    Non Qualified Stock Options (Right to buy)

    Direct
    10K shares-
  • IMMUCELL CORP /DE/ logo
    ICCC

    IMMUCELL CORP /DE/

    Sep 20, 2024
    Award(A)

    Non-Qualified Stock Options (Right to buy)

    Direct
    10K shares at avg. $3.60-

1-3 of 3

About Gathagan Bryan K.

Gathagan Bryan K. (SEC CIK 0001981919) files insider reports with the SEC as Director of IMMUCELL CORP /DE/ (ICCC).

Signal8 holds 3 ownership filings by Gathagan Bryan K., all Form 4s, filed between Sep 24, 2024 and Apr 14, 2026. Those filings report 3 transactions, from Sep 20, 2024 to Jun 12, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Gathagan Bryan K.'s filings is in PORTLAND, ME.

Recent filings by Gathagan Bryan K.

  • Jun 12, 2025: Open-market purchase of ICCC shares (Form 4, code P).
  • Apr 16, 2025: Grant or award of ICCC derivative securities (Form 4, code A).
  • Sep 20, 2024: Grant or award of ICCC derivative securities (Form 4, code A).

Other insiders filing for IMMUCELL CORP /DE/ (ICCC)

How to read Form 4 transaction codes